BiotechTube
Home/Mariana Oncology/Caroline Breitbach, PhD
CB

Caroline Breitbach, PhD

SVP, Asset & Portfolio Leadership

Mariana Oncology

Therapeutic Areas

Oncology

Mariana Oncology Pipeline

DrugIndicationPhase
DLL3-Targeted RLTDLL3-expressing cancers (e.g., small cell lung cancer, neuroendocrine cancers)Preclinical
B7-H3-Targeted RLTB7-H3-expressing solid tumorsPreclinical

Leadership Team at Mariana Oncology

FZ
Fred Zecri, PhD
Chief Scientific Officer – Site Head
TT
Travis Tirrell, MS, JD
Chief Operating Officer and General Counsel
BD
Bill Diamantopoulos, PharmD
Chief Technology Officer
MV
Melissa Vasbinder, PhD
Head of Research
View full Mariana Oncology profile